These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8035102)
1. Experimentally induced renal failure in the dog as an animal model of uremic bleeding. Brassard JA; Meyers KM; Person M; Dhein CR J Lab Clin Med; 1994 Jul; 124(1):48-54. PubMed ID: 8035102 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency. Brassard JA; Meyers KM Thromb Haemost; 1991 Feb; 65(2):191-5. PubMed ID: 2053106 [TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor is not altered in azotemic dogs with prolonged bleeding time. Brassard JA; Meyers KM J Lab Clin Med; 1994 Jul; 124(1):55-62. PubMed ID: 8035104 [TBL] [Abstract][Full Text] [Related]
4. Buccal mucosa bleeding time is prolonged in canine models of primary hemostatic disorders. Brooks M; Catalfamo J Thromb Haemost; 1993 Nov; 70(5):777-80. PubMed ID: 8128434 [TBL] [Abstract][Full Text] [Related]
5. Buccal mucosa bleeding times of healthy dogs and of dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand's disease. Jergens AE; Turrentine MA; Kraus KH; Johnson GS Am J Vet Res; 1987 Sep; 48(9):1337-42. PubMed ID: 3499100 [TBL] [Abstract][Full Text] [Related]
6. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis. Mezzano D; Tagle R; Panes O; Pérez M; Downey P; Muñoz B; Aranda E; Barja P; Thambo S; González F; Mezzano S; Pereira J Thromb Haemost; 1996 Sep; 76(3):312-21. PubMed ID: 8883263 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the buccal mucosal bleeding time in dogs using 3 different-sized lancet devices. Aumann M; Rossi V; Le Boedec K; Diquélou A Vet Clin Pathol; 2013 Dec; 42(4):451-7. PubMed ID: 24131255 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation. Escolar G; Cases A; Viñas M; Pino M; Calls J; Cirera I; Ordinas A Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903 [TBL] [Abstract][Full Text] [Related]
9. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease. Ching YN; Meyers KM; Brassard JA; Wardrop KJ Am J Vet Res; 1994 Jan; 55(1):102-10. PubMed ID: 8141483 [TBL] [Abstract][Full Text] [Related]
10. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting. Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021 [TBL] [Abstract][Full Text] [Related]
11. Thigh bleeding time as a valid indicator of hemostatic competency during surgical treatment of patients with advanced renal disease. Liu YK; Goldstein DM; Arora K; Woo D; Ferris FZ; Marcum SG; Garrison RN; Amin M Surg Gynecol Obstet; 1991 Apr; 172(4):269-74. PubMed ID: 2006450 [TBL] [Abstract][Full Text] [Related]
12. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation. Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373 [TBL] [Abstract][Full Text] [Related]
13. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active. Cook NS; Bruttger O; Pally C; Hagenbach A Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443 [TBL] [Abstract][Full Text] [Related]
14. Prolonged bleeding time and increased vascular prostacyclin in rats with chronic renal failure: effects of conjugated estrogens. Zoja C; Viganò G; Bergamelli A; Benigni A; de Gaetano G; Remuzzi G J Lab Clin Med; 1988 Sep; 112(3):380-6. PubMed ID: 2842417 [TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
16. Impact of calcium antagonists on bleeding time in patients with chronic renal failure. Hayashi K; Matsuda H; Honda M; Ozawa Y; Tokuyama H; Okubo K; Takamatsu I; Kanda T; Tatematsu S; Homma K; Saruta T J Hum Hypertens; 2002 Mar; 16(3):199-203. PubMed ID: 11896510 [TBL] [Abstract][Full Text] [Related]
17. The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients. Brophy DF; Martin EJ; Carr SL; Kirschbaum B; Carr ME Thromb Res; 2007; 119(6):723-9. PubMed ID: 16793120 [TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure. Mezzano D; Panes O; Muñoz B; Pais E; Tagle R; González F; Mezzano S; Barriga F; Pereira J Thromb Haemost; 1999 Oct; 82(4):1250-4. PubMed ID: 10544908 [TBL] [Abstract][Full Text] [Related]
20. Effects of doxycycline, amoxicillin, cephalexin, and enrofloxacin on hemostasis in healthy dogs. Webb JA; Allen DG; Abrams-Ogg AC; Gentry PA Am J Vet Res; 2006 Apr; 67(4):569-76. PubMed ID: 16579747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]